Leiden, Netherlands

Arnaud Nicolas



Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Leiden, NL (2020 - 2022)
  • DH Oegstgeest, NL (2023)

Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Arnaud Nicolas: Innovator in Microfluidic Technology

Introduction

Arnaud Nicolas is a prominent inventor based in Leiden, Netherlands. He has made significant contributions to the field of microfluidics, particularly in the development of devices that enhance cell culture techniques. With a total of 3 patents, his work is paving the way for advancements in biomedical research.

Latest Patents

Nicolas's latest patents include a "Cell culture device and methods," which describes a method of vascularizing a cell aggregate on a microfluidic device. This innovation features microfluidic cell culture devices that comprise perfusable vascular networks, along with kits and assays utilizing these devices. The microfluidic devices are designed with one or more capillary pressure barriers, allowing for the formation of an extracellular matrix gel within a confined area of the network. This setup enables the culture of cells for various applications. Another notable patent is a "Device for inducing microfluidic flow," which further enhances the capabilities of microfluidic systems.

Career Highlights

Arnaud Nicolas is currently associated with Mimetas B.V., a company known for its innovative approaches in the field of organ-on-a-chip technology. His work at Mimetas has been instrumental in advancing the understanding and application of microfluidic devices in biological research.

Collaborations

Nicolas collaborates with talented individuals in his field, including Sebastiaan Johannes Trietsch and Frederik Schavemaker. These collaborations foster a creative environment that drives innovation and enhances the development of new technologies.

Conclusion

Arnaud Nicolas is a key figure in the realm of microfluidic technology, with a focus on improving cell culture methods. His patents and work at Mimetas B.V. reflect his commitment to advancing biomedical research. His contributions are likely to have a lasting impact on the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…